Aleksi Sedo

Prof. Dr. Aleksi Sedo

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Closed access
ASAleksi Sedo
Aleksi Sedo
PBPetr Busek
Petr Busek
RMRosana Mateu
Rosana Mateu
MZMichal Zubal
Michal Zubal
LKLenka Kotackova
Lenka Kotackova
Fibroblast activation protein (FAP, seprase) is a serine protease with post-proline dipeptidyl peptidase and endopeptidase enzymatic activity. FAP is upregulated in several tumor types, while its expression in healthy adult tissues is scarce. FAP molecule itself and FAP+ stromal cells play an important although probably context-dependent and tumor type-specific pathogenetic role in tumor progression. We provide an overview of FAP expression under both physiological and pathological conditions with focus on human malignancies. We also review and critically analyze the results of studies which used various strategies for the therapeutic targeting of FAP including the use of low molecular weight inhibitors, FAP activated prodrugs, anti-FAP antibodies and their conjugates, FAP-CAR T cells, and FAP vaccines. A unique enzymatic activity and selective expression in tumor microenvironment make FAP a promising therapeutic target. A better understanding of its role in individual tumor types, careful selection of patients, and identification of suitable combinations with currently available anticancer treatments will be critical for a successful translation of preclinically tested approaches of FAP targeting into clinical setting.

12 October 2016 in Anticancer Research
Verified
Journal Article
Open access
PDF file
Karel SmetanaKarel Smetana
Karel Smetana
Lukas LacinaLukas Lacina
Lukas Lacina
PSPavol Szabo
Pavol Szabo
BDBarbora Dvorankova
Barbora Dvorankova
PBProkop Brož
Prokop Brož
ASAleksi Sedo
Aleksi Sedo
An ageing population is a typical feature of many developed countries across the world. Analyzed from a biomedical and philosophical point of view, this phenomenon is also a potential risk factor for social sustainability of communities. The association between ageing and cancer seems to be more than apparent. Therefore, the further increase of epidemic-like incidence of malignant tumors in a population can be expected in the near future. Elderly people usually suffer from age-dependent diseases, and such polymorbidity can seriously affect the treatment of malignant tumors. Such an impending situation may be associated with multiple medical, social and economic issues. This article summarizes data about the possible molecular mechanism influencing rapid spreading of tumors in the elderly population. Reduction of the activity of DNA repair machinery is a likely genetic cause. Besides this, even epigenetic mechanisms can influence this process. In this context, the role of cancer stroma in controlling multiple biological properties of tumors is a prospective target for translational research with potential therapeutic outcomes.

1 December 2001 in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
Verified
Journal Article
Closed access
ASAleksi Sedo
Aleksi Sedo
RMRadek Malı́k
Radek Malı́k

4 August 2016 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
PBPetr Bušek
Petr Bušek
EBEva Balaziova
Eva Balaziova
IMIvana Matrasova
Ivana Matrasova
MHMarek Hilser
Marek Hilser
RTRobert Tomas
Robert Tomas
ASAleksi Sedo
Aleksi Sedo

25 February 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
JTJana Trylcova
Jana Trylcova
PBPetr Bušek
Petr Bušek
Karel SmetanaKarel Smetana
Karel Smetana
EBEva Balaziova
Eva Balaziova
BDBarbora Dvorankova
Barbora Dvorankova
ASAleksi Sedo
Aleksi Sedo

1 July 2020 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
AŠAdéla Šimková
Adéla Šimková
PBPetr Bušek
Petr Bušek
ASAleksi Sedo
Aleksi Sedo
JKJan Konvalinka
Jan Konvalinka